Recap: PMV Pharma Q3 Earnings
Portfolio Pulse from Benzinga Insights
PMV Pharma (NASDAQ:PMVP) reported its Q3 earnings, beating estimated earnings by 24.44% with an EPS of $-0.34 versus an estimate of $-0.45. However, revenue was down $0 from the same period last year. Last quarter, the company beat on EPS by $0.09, which was followed by a 1.38% increase in the share price the next day.
November 09, 2023 | 1:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
PMV Pharma's Q3 earnings beat estimates by 24.44%, but revenue was unchanged from last year. Last quarter's earnings beat led to a 1.38% share price increase the next day.
PMV Pharma's earnings beat is a positive signal to investors, which could lead to a short-term increase in the stock price, similar to the 1.38% increase observed after last quarter's earnings beat. However, the unchanged revenue might temper some of the enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100